426264-61-1
Chemical Structure
D-K6L9
- CAS No.: 426264-61-1
- Formula:C90H174N22O15
- Molecular Weight:1804.48
InChIKey: MGRVUOHLBGAMAI-SUKDZJCISA-N
SMILES: CC(C)C[C@@H](C(N)=O)NC([C@H](CC(C)C)NC([C@@H](CCCCN)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CCCCN)NC([C@@H](CCCCN)NC([C@@H](CC(C)C)NC([C@H](CC(C)C)NC([C@@H](CCCCN)NC([C@H](CCCCN)NC([C@H](CC(C)C)NC([C@@H](CC(C)C)NC([C@H](CCCCN)NC([C@@H](N)CC(C)C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
Biological Activity: D-K6L9 shows antimicrobial and antibiofilm activities against P. aeruginosa from cystic fibrosis patients. D-K6L9 is stable and resistant to degradation by cystic fibrosis sputum proteases and will not induce bacterial resistance [1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
D-K6L9 | D-K6L9 shows antimicrobial and antibiofilm activities against P. aeruginosa from cystic fibrosis patients. D-K6L9 is stable and resistant to degradation by cystic fibrosis sputum proteases and will not induce bacterial resistance . | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
